JOUNCE THERAPEUTICS INC's ticker is and the CUSIP is 481116901. A total of 3 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $109,150 | +1459.3% | 59,000 | +1866.7% | 0.00% | – |
| Q3 2022 | $7,000 | +600.0% | 3,000 | +650.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 400 | -20.0% | 0.00% | – |
| Q1 2022 | $3,000 | -83.3% | 500 | -77.3% | 0.00% | – |
| Q4 2021 | $18,000 | -89.8% | 2,200 | -90.8% | 0.00% | – |
| Q3 2021 | $177,000 | +1375.0% | 23,800 | +1300.0% | 0.00% | – |
| Q2 2021 | $12,000 | -88.1% | 1,700 | -82.7% | 0.00% | – |
| Q1 2021 | $101,000 | -47.7% | 9,800 | -64.5% | 0.00% | – |
| Q4 2020 | $193,000 | +38.8% | 27,600 | +62.4% | 0.00% | – |
| Q3 2020 | $139,000 | -42.8% | 17,000 | -51.7% | 0.00% | -100.0% |
| Q2 2020 | $243,000 | +3371.4% | 35,200 | +2414.3% | 0.00% | – |
| Q1 2020 | $7,000 | -97.5% | 1,400 | -95.7% | 0.00% | -100.0% |
| Q4 2019 | $282,000 | +182.0% | 32,300 | +100.6% | 0.00% | +100.0% |
| Q1 2019 | $100,000 | +3233.3% | 16,100 | +1510.0% | 0.00% | – |
| Q4 2018 | $3,000 | -99.5% | 1,000 | -98.9% | 0.00% | -100.0% |
| Q3 2018 | $566,000 | -63.0% | 87,100 | -56.4% | 0.00% | -69.2% |
| Q2 2018 | $1,530,000 | -25.4% | 199,800 | +117.6% | 0.01% | -38.1% |
| Q1 2018 | $2,052,000 | – | 91,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|